$1.53
0.01[0.66%]
Last update: 9:29AM Get Real Time Here
SELLAS Life Sciences Gr
(NASDAQ:SLS)SELLAS Life Sciences Gr Stock (NASDAQ:SLS), Analyst Ratings, Price Targets, Predictions
SELLAS Life Sciences Group Inc has a consensus price target of $9.67, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and Alliance Global Partners on November 22, 2023, September 7, 2023, and November 15, 2022. With an average price target of $4.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Alliance Global Partners, there's an implied 205.01% upside for SELLAS Life Sciences Group Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Alliance Global Partners
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for SELLAS Life Sciences Gr
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/22/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.53 | 96.08% | Cantor Fitzgerald | Li Watsek | → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.53 | 96.08% | Cantor Fitzgerald | Li Watsek | → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2022 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.53 | 422.88% | Alliance Global Partners | James Molloy | $14 → $8 | Maintains | Buy | Get Alert |
| 06/28/2022 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.53 | 292.16% | Cantor Fitzgerald | Li Watsek | $10 → $6 | Maintains | Overweight | Get Alert |
| 07/21/2021 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.53 | 1076.47% | Cantor Fitzgerald | — | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for SELLAS Life Sciences Gr (SLS)?
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on November 22, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 96.08% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.
When was the last upgrade for SELLAS Life Sciences Gr (SLS)?
There is no last upgrade for SELLAS Life Sciences Gr.
When was the last downgrade for SELLAS Life Sciences Gr (SLS)?
There is no last downgrade for SELLAS Life Sciences Gr.
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $1.53, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.